Allianz Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Hold |
9,400
| – | – | ﹤0.01% | 1461 |
|
|
2025
Q1 | $315K | Sell |
9,400
-3,000
| -24% | -$101K | ﹤0.01% | 1556 |
|
|
2024
Q4 | $486K | Buy |
12,400
+4,300
| +53% | +$169K | ﹤0.01% | 1423 |
|
|
2024
Q3 | $319K | Sell |
8,100
-2,900
| -26% | -$114K | ﹤0.01% | 1524 |
|
|
2024
Q2 | $429K | Sell |
11,000
-6,400
| -37% | -$250K | ﹤0.01% | 1454 |
|
|
2024
Q1 | $749K | Hold |
17,400
| – | – | ﹤0.01% | 1316 |
|
|
2023
Q4 | $801K | Buy |
17,400
+4,200
| +32% | +$193K | ﹤0.01% | 1284 |
|
|
2023
Q3 | $451K | Hold |
13,200
| – | – | ﹤0.01% | 1474 |
|
|
2023
Q2 | $508 | Sell |
13,200
-6,800
| -34% | -$262 | ﹤0.01% | 1609 |
|
|
2023
Q1 | $716K | Hold |
20,000
| – | – | ﹤0.01% | 1351 |
|
|
2022
Q4 | $789K | Hold |
20,000
| – | – | ﹤0.01% | 1267 |
|
|
2022
Q3 | $722K | Sell |
20,000
-68,630
| -77% | -$2.48M | ﹤0.01% | 1256 |
|
|
2022
Q2 | $2.7M | Sell |
88,630
-13,555
| -13% | -$412K | ﹤0.01% | 1209 |
|
|
2022
Q1 | $3.12M | Buy |
102,185
+32,280
| +46% | +$987K | ﹤0.01% | 1241 |
|
|
2021
Q4 | $2.19M | Buy |
+69,905
| New | +$2.19M | ﹤0.01% | 1375 |
|